Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 972.3 M1.17 B1.05 B1.12 B 4.31 B Research & development ———— — Operating income 328.2 M716.4 M427.5 M442.3 M 1.91 B Non-Operating Income, Total 3.3 M-1.9 M1.6 M-1.6 M 1.4 M Interest expense, net of interest capitalized 30.1 M30.9 M29.3 M29 M 119.3 M Non-Operating Income, excl. Interest Expenses -30.1 M-30.9 M-29.3 M-29 M -119.3 M Unusual income/expense 3.3 M-1.9 M1.6 M-1.6 M 1.4 M Pretax income 318.7 M697.1 M416 M428.8 M 1.86 B Equity in earnings ———— — Taxes 43.9 M135.8 M72.2 M81 M 332.9 M Non-controlling/minority interest ———— — After tax other income/expense -2.7 M9.3 M11.7 M9.4 M 27.7 M Net income before discontinued operations 274.8 M561.3 M343.8 M347.8 M 1.53 B Discontinued operations ———— — Net income 274.8 M561.3 M343.8 M347.8 M 1.53 B Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 274.8 M561.3 M343.8 M1.42 B 2.6 B Basic earnings per share (Basic EPS) 1.322.751.71.72 7.49 Diluted earnings per share (Diluted EPS) 1.282.681.656.74 7.27 Average basic shares outstanding 207.6 M204.1 M202.5 M204 M — Diluted shares outstanding 215.5 M209.8 M208.3 M210.2 M — EBITDA 312.1 M693.6 M411.5 M— — EBIT 274.9 M654.6 M372.1 M— — Cost of revenue 404.1 M614 M444.1 M313 M 1.78 B Other cost of goods sold ———— — Depreciation & amortization (cash flow) 37.2 M39 M39.4 M45.2 M 160.8 M